Delivery Order SPE2DB20D9136-SPE2DB25FJ58U

Award Date 2/25/25
Potential Completion Date 3/18/25
Potential Value $9.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $29,214.45, is a firm fixed-price delivery order for the supply of OCALIVA 5 MG TABLET 30S, a specialized pharmaceutical product. The contract has no set-aside designation and is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical...
This federal contract award, valued at $35,000.32, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award is a firm fixed-price delivery order under the DLA's SPE2DB program, a single-award indefinite delivery contract (IDC) valued up to $499,999,999 through December 31, 2025. This IDC enables the DLA to procure a comprehensive range of pharmaceutical items, from common...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $17,497.94 firm fixed-price delivery order is for the provision of 4566758775 - OCALIVA 5 MG TABLET 30S, a specialized pharmaceutical product. This award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which covers a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,748.97 firm fixed-price delivery order is for the supply of 4565693343 ! OCALIVA 5 MG TABLET 30S. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This single-award IDC allows the DLA to issue...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award is a delivery order under the DLA's SPE2DB Indefinite Delivery Contract (IDC), valued at $8,748.97, for the supply of the prescription drug Ocaliva 5 mg tablets. The IDC, which has a total potential value of $499,999,999 and is valid through November 2026, enables the DLA to issue firm...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,748.97 firm fixed-price delivery order is for the supply of the prescription drug OCALIVA 5 MG TABLET 30S. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the DLA to issue delivery...
The Defense Logistics Agency (DLA) awarded a $26,246.91 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4565006427 - OCALIVA 5 MG TABLET 30S. This delivery order is placed against a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with DLA, which provides pharmaceutical products and medical supplies to...
This is a federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $8,751.19, is for the delivery of the prescription drug OCALIVA 10 MG TABLET 30S. The contract was awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain division, with no set-aside designation. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the...
This federal contract award, valued at $26,068.56, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of various pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. The award is part of a larger indefinite delivery contract...
  • SPE2DB20D9136
    Indefinite Delivery Contract
  • SPE2DB20D9136-SPE2DB25FJ58U
    Delivery Order

The federal contract award, valued at $9,738.15, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of 4567403444 OCALIVA 5 MG TABLET 30S, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The IDC enables the DLA to issue delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide. The contract does not have a set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure direct federal awards across multiple product categories and medical domains.

Generated 6/1/25, 3:31 AM